In this Issue
Glaucoma medical therapy today and tomorrow
By Steven D. Vold, MD
By Jonathan Paul, MD, and Sheila Sanders, MD
Bench To Bedside
Industry weighs in on the IOP measurement discussion.
By David A. Taylor and Dan Eisenberg, MD
By Aakriti Garg, MD; James Murphy, MD; and Lama A. Al-Aswad, MD, MPH
Advice for surgeons interested in adopting this procedure.
By Michael G. Morgan, MD
Considerations in treating the advanced elderly.
By Samuel P. Solish, MD
Residents And Fellows
By Felina Z. Kremer, MD
Cover Focus: Today and Tomorrow
What is maximal medical therapy today? Three physicians share their thoughts.
By Howard Barnebey, MD; Carla J. Siegfried, MD; and Julia Song, MD
Its scope and strategies for its reduction.
By Henry D. Jampel, MD, MHS
A mainstay of glaucoma management today and tomorrow.
By Robert D. Fetchner, MD, and Albert S. Khouri, MD
Options for decreasing ocular toxicity in patients with glaucoma.
By Arkadiy Yadgarov, MD, and Reena A. Garg, MD
New medications give fresh hope for treating glaucoma.
By Jason Bacharach, MD
Several devices are being investigated.